المؤلفون: Tian, Hai-Ying, Yu, Dao-Jiang, Xie, Teng, Xu, Meng-Xia, Wang, Yu-Hao, Sun, Xi-Lu, Zhou, Xin-Meng, Han, Ying-Xuan, Liao, Qing-Qing, Zhao, Yu-Jie, Liao, Juan, El-Kassas, Mohamed, Sun, Xiao-Dong, Zhang, Yuan-Yuan

المساهمون: National Natural Science Foundation of China

المصدر: Biochemical Pharmacology ; volume 232, page 116750 ; ISSN 0006-2952

الاتاحة: https://doi.org/10.1016/j.bcp.2025.116750
https://api.elsevier.com/content/article/PII:S0006295225000127?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0006295225000127?httpAccept=text/plain

المؤلفون: Zhu, Bao-Ting, Liao, Qing-Qing, Tian, Hai-Ying, Yu, Dao-Jiang, Xie, Teng, Sun, Xi-Lu, Zhou, Xin-Meng, Han, Ying-Xuan, Zhao, Yu-Jie, El-Kassas, Mohamed, Liu, Xiu-Xiu, Sun, Xiao-Dong, Zhang, Yuan-Yuan

المصدر: Frontiers in Pharmacology; 2024, p1-19, 19p

مصطلحات موضوعية: HORMONE therapy, NON-alcoholic fatty liver disease, ESTROGEN replacement therapy, TYPE 2 diabetes, SEXUAL dimorphism